SCHEMBL5686482

SCHEMBL5686482

COc1cc(OCC(=O)N2CCCC2)ccc1Oc1ncncc1C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.48
▸ POLB P06746 2/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ TP53 P04637 4/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ RAB9A P51151 3/20 0.46
▸ NPC1 O15118 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ MAPT P10636 1/20 0.43
▸ CBX7 O95931 3/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4496196 0.73 NPC1 (0.45) ALDH1A1POLBL3MBTL1SMN1; SMN2KDM4E
SCHEMBL5824566 0.71 KDR (0.57) —
SCHEMBL1930008 0.68 ALDH1A1 (0.69) ALDH1A1POLBL3MBTL1TDP1SMN1; SMN2
SCHEMBL13946459 0.68 SMN1; SMN2 (0.64) ALDH1A1POLBL3MBTL1TDP1SMN1; SMN2
SCHEMBL5056246 0.67 ALDH1A1 (0.69) ALDH1A1TDP1TP53SMN1; SMN2KDM4E
SCHEMBL31582882 0.67 NNMT (0.45) ALDH1A1POLBTDP1KDM4EHPGD
SCHEMBL30509874 0.67 NNMT (0.45) ALDH1A1POLBTDP1KDM4EHPGD
SCHEMBL5056153 0.66 CYP3A4 (0.62) ALDH1A1TP53SMN1; SMN2KDM4EMAPT
SCHEMBL4501636 0.66 MKNK1 (0.46) L3MBTL1HPGDMAPTLMNAMEN1
SCHEMBL5753229 0.66 ALDH1A1 (0.69) ALDH1A1POLBL3MBTL1TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648464-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINCARBOXAMID DERIVATIVES AND RELATED COMPOUNDS AS T-CELL ACTIVATION INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS AMGEN INC. (US) 2006-04-26 — — EP disclosed
WO-2005009443-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF T CELL ACTIVATION FOR THE TREATMENT OF INFLAMMATORY DISEASES AMGEN INC. (US) 2005-02-03 — — WO disclosed
Send feedback